DEA-New York Division: Nine Charged Following Investigation Into Manufacturing and Interstate Trafficking of Counterfeit Oxycodone Pills Containing Fentanyl
March 30, 2023
March 30, 2023
NEW YORK, March 30 -- The U.S. Department of Justice's Drug Enforcement Administration's New York Division issued the following news release on March 29, 2023:
Following a long-term wiretap investigation into the manufacturing and interstate trafficking of counterfeit oxycodone pills containing fentanyl, nine individuals were indicted on charges filed by the Office of the Special Narcotics Prosecutor (SNP) in Manhattan Supreme Court. The charges stem from narcotics-related activity . . .
Following a long-term wiretap investigation into the manufacturing and interstate trafficking of counterfeit oxycodone pills containing fentanyl, nine individuals were indicted on charges filed by the Office of the Special Narcotics Prosecutor (SNP) in Manhattan Supreme Court. The charges stem from narcotics-related activity . . .